The pro-inflammatory environment resulting from hyperglycemia and/or insulin resistance is the result of the higher expression of inflammatory mediators, such as IL-1β, IL-6, TNF-α, TGF-β, IKKβ, and JNK, that may have local or systemic action. The gene discussed is IL1B; the disease is Hyperglycemia.